UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use
Our findings demonstrate both benefits and risks of psilocybin use in this population. Carefully designed clinical trials focused on safety and preliminary efficacy are warranted.
Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
The subjective benefits of psilocybin use for mental health symptoms reported by survey participants encourage further investigation of psilocybin-based treatments for BD.
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
These results suggest that a single, moderate dose of psilocybin significantly reduces depressive symptoms compared to a placebo condition for at least two weeks.
Psychedelics and mortality: A conversation with Roland Griffiths
Sam Harris speaks with Roland Griffiths about psychedelics and mortality.
Psychedelic science of spirituality and religion: An attachment-Informed agenda proposal
we discuss the role of religion and spirituality in psychedelic experiences from an attachment perspective.
Entheogenic spirituality: Characteristics of spiritually motivated psychedelics use
The study affirms the existence of a movement of spiritually motivated entheogen users that requires further investigation.
Psychedelic drug legislative reform and legalization in the US
Most bills (43 [58%]) proposed decriminalization, of which few delineated medical oversight (10 of 43 [23%]) or training and/or licensure requirements (15 of 43 [35%]).
Tune in, turn on: Religious music and spiritual power in the history of psychedelic therapy
We examine how religious sounds and music were both incorporated into and strategically avoided in the early psychedelic therapeutic sessions in an effort to achieve spiritual epiphanies.
The economics of psychedelic-assisted therapies: A research agenda
We describe six types of economic analyses and their rationale for decisions and planning including the needs of health care payers.
Classic psychedelics, health behavior, and physical health
Psychological insight during a classic psychedelic experience may lead to positive health behavior change and better physical health.
Therapeutic use of psilocybin: Practical considerations for dosing and administration
Our goal is to increase the knowledge and comfort of health care professionals to discuss and counsel their patients on psilocybin therapy.
Lower-dose psycholytic therapy – A neglected approach
The article provides comprehensive background information and outlines the essential features of psycholytic therapy.
Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial
Using a patient-informed regimen, we conducted an exploratory randomized, double-blind, placebo-controlled study to systematically investigate the effects of psilocybin in cluster headache.
MAPS PBC completes second phase 3 “MAPP2” trial of MDMA-assisted therapy for treatment of PTSD
The top-line results are expected in the first quarter of 2023.
Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability
Despite the methodological limitations, we conclude that from a clinical view, maintenance ketamine treatment seems to be of therapeutic potential.